New infectious agents pose new risks for people with bleeding disorders, Jefferson Hematologist says

An international team of scientists, including a hematologist from Thomas Jefferson University in Philadelphia, has concluded that people with bleeding disorders such as hemophilia remain at risk from emerging infectious agents in plasma and blood transfusions. For this reason, recombinant therapies, that is, those produced in the laboratory, must always be an option. more  

Findings advance use of adult stem cells for replacement bone

In a significant advance for regenerative medicine, researchers at Rice University have discovered a new way to culture adult stem cells from bone marrow such that the cells themselves produce a growth matrix that is rich in important biochemical growth factors. more

UCLA researches heart disease-glucose connection

Men with cardiovascular disease may be at considerably increased risk for death even when their blood sugar level remains in the "normal" range, suggests a new study by a team of scientists at UCLA and Cedars-Sinai Medical Center in Los Angeles. The study, a statistical analysis examining the connection between glucose (blood sugar) levels and death in patients with cardiovascular disease, will be published Feb. 15 in the American Journal of Epidemiology, the leading scientific journal in its field. more  

Worldwide study looks to find causes of type 1 diabetes

Scientists are casting a wide, tightly woven net with the goal of catching the causes of type 1 diabetes. Study sites around the world are screening 220,800 healthy babies for genes that put them at risk for type 1 diabetes. more

U of MN researchers identify new cord blood stem cell 

Researchers at the University of Minnesota Medical School have discovered a new population of cells in human umbilical cord blood that have properties of primitive stem cells. more

Dutch study finds four in 10 heart attacks go unrecognized  

Dutch researchers who assessed over 4,000 men and women over 55 to see how many heart attacks went undiagnosed at the time they occurred, found that the figure was more than four in 10. Their report is published (Tuesday 14 February) in Europe's leading cardiology journal European Heart Journal[1], which is the journal of the European Society of Cardiology. more

Costs of 'polypill' could drain global health budgets

Treating everyone, or those at only moderate risk of cardiovascular disease, with the polypill would not save any money at all, even if the drug cost nothing to make, finds research in the Journal of Epidemiology and Community Health. more